Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Renal Insufficiency 2Multiple Myeloma 2Kidney Failure, Chronic 2Kidney Diseases 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 12fludarabine 10fludarabine phosphate 7Radiotherapy 6Mycophenolic Acid 6Whole-Body Irradiation 5Sirolimus 5Filgrastim 5Tacrolimus 4Melphalan 4Busulfan 4Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Cyclosporine 3Thiotepa 2Stem Cell Transplantation 2Specimen Handling 2Rituximab 2Methotrexate 2Mesna 2Granulocyte Colony-Stimulating Factor 2Etoposide 2venetoclax 1siplizumab 1rasburicase 1prostaglandin D2 receptor 1milatuzumab 1itacitinib 1eritoran 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Graft vs Host Disease × Kidney Transplantation × Clear all
NCT00062621 2013-02-05

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
5 enrolled
GenitourinaryPlasma cell

Graft vs Host Disease, Kidney Diseases, Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡